Cheng Hang,Zeng Fangyin,Hu Qiwen,Yuan Wenchang,Zhou Renjie,Zhang Xia,Yuan Jizhen,Shang Weilong,Yang Jie,Hu Zhen,Zhu Junmin,Rao Xiancai.Molecular typing and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus isolated from Guangzhou, China[J].J Amry Med Univ (J Third Mil Med Univ),2013,35(08):696-701.
Cheng Hang,Zeng Fangyin,Hu Qiwen,Yuan Wenchang,Zhou Renjie,Zhang Xia,Yuan Jizhen,Shang Weilong,Yang Jie,Hu Zhen,Zhu Junmin,Rao Xiancai.Molecular typing and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus isolated from Guangzhou, China[J].J Amry Med Univ (J Third Mil Med Univ),2013,35(08):696-701.DOI:
Molecular typing and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus isolated from Guangzhou, China
Objective To determine the molecular types and drug susceptibilities of methicillin-resistant Staphylococcus aureus (MRSA) prevailed in Guangzhou
China. Methods A total of 142 MRSA isolates were collected between October 2010 and April 2011 from two teaching hospitals in Guangzhou. The molecular typing methods
such as staphylococcal cassette chromosome mec (SCCmec) typing
staphylococcal protein A (spa) typing
multilocus sequence typing (MLST)
and pulsed-field gel electrophoresis (PFGE)
were applied for all MRSA strains
and the drug susceptibilities to 17 kinds of antibiotics were also determined. Results In the 142 MRSA isolates
there were 121 hospital-associated isolates (HA-MRSA)
20 community-associated isolates (CA-MRSA)
and 1 non typeable MRSA. Sixteen spa types
eight sequence types (ST)
and thirteen PFGE types were found. The major predominant clones were ST239-MRSA-Ⅲ-t030
ST239-MRSA-Ⅲ-t037 and ST5-MRSA-Ⅱ-t002 that belong to HA-MRSA. Furthermore
colne ST59-MRSA-Ⅳ-t437 that belongs to CA-MRSA was also found to be prevailed in Guangzhou. The major prevailed clones with specific drug resistant profiles were found. Conclusion HA-MRSA is still the most predominant MRSA in Guangzhou
and CA-MRSA with decreasing drug susceptibility is also found. It is the time to monitor the prevalence of CA-MRSA and drug resistance of MRSA.